In summary, our study implies that itaconate significantly decreases the radiosensitivity of NSCLC by enhancing the survival of cancer cells and suppressing CD8+ T cells within the tumor microenvironment (TME). The gene discussed is CD8A; the disease is non-small cell lung carcinoma.